-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VPK9WA5FFxeNmkYi6mVoy7hRK1yA+BJwOJcaxmR1QP8cA56RqSvPc4fA+sGSXMVk oGRUO2DcBitERLrsrQF2mw== 0000912057-97-011383.txt : 19970401 0000912057-97-011383.hdr.sgml : 19970401 ACCESSION NUMBER: 0000912057-97-011383 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970331 SROS: NONE GROUP MEMBERS: FRED A MIDDLETON GROUP MEMBERS: SANDERLING BIOMEDICAL L.P. GROUP MEMBERS: SANDERLING III BIOMEDICAL,L.P. GROUP MEMBERS: SANDERLING III LIMITED PARTNERSHIP GROUP MEMBERS: SANDERLING VENTURE PARTNERS II, L.P. GROUP MEMBERS: SANDERLING VENTURE PARTNERS III GROUP MEMBERS: SANDERLING VENTURES GROUP MEMBERS: SANDERLING VENTURES LIMITED, L.P. GROUP MEMBERS: SANDERLING VENTURES MANAGEMENT SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COCENSYS INC CENTRAL INDEX KEY: 0000895034 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330538836 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-42753 FILM NUMBER: 97570975 BUSINESS ADDRESS: STREET 1: 213 TECHNOLOGY DR CITY: IRVINE STATE: CA ZIP: 92718 BUSINESS PHONE: 7147536100 MAIL ADDRESS: STREET 2: 213 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92718 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SANDERLING VENTURES CENTRAL INDEX KEY: 0001036779 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 2730 SAND HILL ROAD, SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 SC 13D 1 SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 COCENSYS, INC. -------------------------------------------------------- (Name of Issuer) COMMON STOCK -------------------------------------------------------- (Title of Class of Securities) 191263 10 2 -------------------------------------------------------- (CUSIP Number) PETER E. JANSEN COCENSYS, INC. 213 TECHNOLOGY DRIVE IRVINE, CA 94112 -------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) FEBRUARY 12, 1997 -------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box / /. Check the following box if a fee is being paid with this statement / /. (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class. (See Rule 13d-7.) NOTE: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) Page 1 of 15 Pages CUSIP No. 191263 10 2 13D Page 2 of 15 Pages - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Robert G. McNeil - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) /X/ of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Source of Funds* - ------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- (6) Citizenship or Place of Organization California - ------------------------------------------------------------------------------- Number of Shares (7) Sole Voting Power Beneficially Owned 159,658 by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power 2,302,915 -------------------------------------------------- (9) Sole Dispositive Power 159,658 -------------------------------------------------- (10) Shared Dispositive Power 2,302,915 - ------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 2,462,573 - ------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row (11) 10.9% - ------------------------------------------------------------------------------- (14) Type of Reporting Person* IN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 191263 10 2 13D Page 3 of 15 Pages - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Fred A. Middleton - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) /X/ of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Source of Funds* - ------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- (6) Citizenship or Place of Organization California - ------------------------------------------------------------------------------- Number of Shares (7) Sole Voting Power Beneficially Owned 92,932 by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power 2,302,915 -------------------------------------------------- (9) Sole Dispositive Power 92,932 -------------------------------------------------- (10) Shared Dispositive Power 2,302,915 - ------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 2,395,847 - ------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row (11) 10.6% - ------------------------------------------------------------------------------- (14) Type of Reporting Person* IN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 191263 10 2 13D Page 4 of 15 Pages - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Sanderling Venture Partners III, L.P. - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) /X/ of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Source of Funds* - ------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- (6) Citizenship or Place of Organization California - ------------------------------------------------------------------------------- Number of Shares (7) Sole Voting Power Beneficially Owned 882,394 by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power 0 -------------------------------------------------- (9) Sole Dispositive Power 882,394 -------------------------------------------------- (10) Shared Dispositive Power 0 - ------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 882,394 - ------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row (11) 3.9% - ------------------------------------------------------------------------------- (14) Type of Reporting Person* PN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 191263 10 2 13D Page 5 of 15 Pages - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Sanderling III Biomedical, L.P. - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) /X/ of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Source of Funds* - ------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- (6) Citizenship or Place of Organization California - ------------------------------------------------------------------------------- Number of Shares (7) Sole Voting Power Beneficially Owned 179,601 by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power 0 -------------------------------------------------- (9) Sole Dispositive Power 179,601 -------------------------------------------------- (10) Shared Dispositive Power 0 - ------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 179,601 - ------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row (11) 0.8% - ------------------------------------------------------------------------------- (14) Type of Reporting Person* PN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 191263 10 2 13D Page 6 of 15 Pages - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Sanderling III Limited Partnership - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) /X/ of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Source of Funds* - ------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- (6) Citizenship or Place of Organization Cayman Islands - ------------------------------------------------------------------------------- Number of Shares (7) Sole Voting Power Beneficially Owned 465,247 by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power 0 -------------------------------------------------- (9) Sole Dispositive Power 465,247 -------------------------------------------------- (10) Shared Dispositive Power 0 - ------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 465,247 - ------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row (11) 2.1% - ------------------------------------------------------------------------------- (14) Type of Reporting Person* PN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 191263 10 2 13D Page 7 of 15 Pages - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Sanderling Ventures Management - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) /X/ of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Source of Funds* - ------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- (6) Citizenship or Place of Organization California - ------------------------------------------------------------------------------- Number of Shares (7) Sole Voting Power Beneficially Owned 0 by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power 0 -------------------------------------------------- (9) Sole Dispositive Power 0 -------------------------------------------------- (10) Shared Dispositive Power 0 - ------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 0 - ------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row (11) 0% - ------------------------------------------------------------------------------- (14) Type of Reporting Person* PN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 191263 10 2 13D Page 8 of 15 Pages - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Sanderling Venture Partners II, L.P. - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) /X/ of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Source of Funds* - ------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- (6) Citizenship or Place of Organization California - ------------------------------------------------------------------------------- Number of Shares (7) Sole Voting Power Beneficially Owned 388,224 by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power 0 -------------------------------------------------- (9) Sole Dispositive Power 388,224 -------------------------------------------------- (10) Shared Dispositive Power 0 - ------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 388,224 - ------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row (11) 1.7% - ------------------------------------------------------------------------------- (14) Type of Reporting Person* PN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 191263 10 2 13D Page 9 of 15 Pages - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Sanderling Ventures Limited, L.P. - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) /X/ of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Source of Funds* - ------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- (6) Citizenship or Place of Organization Cayman Islands - ------------------------------------------------------------------------------- Number of Shares (7) Sole Voting Power Beneficially Owned 196,815 by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power 0 -------------------------------------------------- (9) Sole Dispositive Power 196,815 -------------------------------------------------- (10) Shared Dispositive Power 0 - ------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 196,815 - ------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row (11) 0.9% - ------------------------------------------------------------------------------- (14) Type of Reporting Person* PN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 191263 10 2 13D Page 10 of 15 Pages - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Sanderling Biomedical L.P. - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) /X/ of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Source of Funds* - ------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- (6) Citizenship or Place of Organization California - ------------------------------------------------------------------------------- Number of Shares (7) Sole Voting Power Beneficially Owned 190,634 by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power 0 -------------------------------------------------- (9) Sole Dispositive Power 190,634 -------------------------------------------------- (10) Shared Dispositive Power 0 - ------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 190,634 - ------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row (11) 0.8% - ------------------------------------------------------------------------------- (14) Type of Reporting Person* PN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 11 of 15 Pages ITEM 1. SECURITY AND ISSUER Class of Securities: Common Stock Issuer: CoCensys, Inc. ("Issuer") Principal Address:: 213 Technology Drive Irvine, CA 92718 ITEM 2. IDENTITY AND BACKGROUND (a) Reporting Persons: 1. Robert G. McNeil ("McNeil") 2. Fred A. Middleton ("Middleton") 3. Sanderling Venture Partners III, L.P. ("SVPIII") 4. Sanderling III Biomedical, L.P. ("SIIIB") 5. Sanderling III Limited Partnership ("SIIILP") vi. Sanderling Ventures Management ("SVM") vii. Sanderling Venture Partners II, L.P. ("SVPII") viii. Sanderling Ventures Limited, L.P. ("SVL") ix. Sanderling Biomedical, L.P. ("SB"; together with persons i through viii, the "Reporting Persons"; and together with persons iii through viii, the "Venture Fund Reporting Persons") (b) Principal Business Address: 2730 Sand Hill Road, Suite 200 Menlo Park, CA 94025 (c) Principal Occupation/Principal Business: McNeil: General Partner of each of the Venture Fund Reporting Persons Middleton: General Partner of each of the Venture Fund Reporting Persons SVPIII: Venture Capital Fund SIIIB: Venture Capital Fund SIIILP: Venture Capital Fund SVM: Venture Capital Fund SVPII: Venture Capital Fund SVL: Venture Capital Fund Page 12 of 15 Pages SB: Venture Capital Fund (d) Not applicable. (e) Not applicable. (f) Citizenship or Place of Organization: McNeil: USA Middleton: USA SVPIII: California SIIIB: California SIIILP: Cayman Islands SVM: California SVPII: California SVL: Cayman Islands SB: California ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION Not applicable ITEM 4. PURPOSE OF TRANSACTION Not applicable ITEM 5. INTEREST IN SECURITIES OF THE ISSUER The following table sets forth certain information with respect to the beneficial ownership of Issuer's common stock by the Reporting Persons. The percentages set forth in the table reflect 22,516,863 shares outstanding as certified to the Issuer on March 20, 1997 by the Issuer's transfer agent, American Stock Transfer & Trust Company. Page 13 of 15 Pages
- ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- McNeil Middleton SVPIII SIIIB SIIILP SVM SVPII* SVL* SB - ----------------------------------------------------------------------------------------------------------------------------- Beneficial 2,462,573** 2,395,847 882,394 179,601 465,247 -0- 388,224 196,815 190,634 Ownership - ----------------------------------------------------------------------------------------------------------------------------- Percentage of 10.9% 10.6% 3.9% 0.8% 2.1% -0- 1.7% 0.9% 0.8% Class - ----------------------------------------------------------------------------------------------------------------------------- Sole Voting 159,658 92,932 882,394 179,601 465,247 -0- 388,224 196,815 190,634 Power - ----------------------------------------------------------------------------------------------------------------------------- Shared Voting 2,302,915 2,302,915 -0- -0- -0- -0- -0- -0- -0- Power - ----------------------------------------------------------------------------------------------------------------------------- Sole Dispositive 159,658 92,932 882,394 179,601 465,247 -0- 388,224 196,815 190,634 Power - ----------------------------------------------------------------------------------------------------------------------------- Shared 2,302,915 2,302,915 -0- -0- -0- -0- -0- -0- -0- Dispositive Power - ----------------------------------------------------------------------------------------------------------------------------- - -----------------------------------------------------------------------------------------------------------------------------
* The shares of Issuer Common Stock beneficially owned by these Reporting Persons are subject to voluntary distribution from time to time at the request of their respective limited partners. ** Includes options to acquire 60,000 shares of Issuer's Common Stock 44,000 of which are presently exercisable. (c) See Item 3 above. (d) Not applicable. (e) Not applicable. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. To the best knowledge of the undersigned, there are no contracts, understandings, arrangements, or relationships (legal or otherwise) giving the persons named in Item 2 and between such persons and any person with respect to the securities of Issuer, including, but not limited to, transfer or voting of any of the Issuer's securities, finder's fees, joint ventures, loan or option agreement, puts or calls, guarantees of profits, divisions of profits or loss, or the giving or withholding of proxies. ITEM 7. EXHIBITS. Exhibit A: Joint Filing Statement. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. /s/ Robert G. McNeil - ----------------------------------- Robert G. McNeil /s/ Fred A. Middleton - ----------------------------------- Fred A. Middleton Sanderling Venture Partners III, L.P. Sanderling III Limited Partnership Sanderling III Biomedical, L.P. Sanderling Ventures Management Sanderling Venture Partners II, L.P. Sanderling Ventures Limited, L.P. Sanderling Biomedical, L.P. /s/ Fred A. Middleton - ----------------------------------- Fred A. Middleton General Partner EXHIBIT A JOINT FILING STATEMENT We, the undersigned, hereby express our agreement that the attached Schedule 13D is filed on behalf of each of us. /s/ Robert G. McNeil - ----------------------------------- Robert G. McNeil /s/ Fred A. Middleton - ----------------------------------- Fred A. Middleton Sanderling Venture Partners III, L.P. Sanderling III Limited Partnership Sanderling III Biomedical, L.P. Sanderling Ventures Management Sanderling Venture Partners II, L.P. Sanderling Ventures Limited, L.P. Sanderling Biomedical, L.P. /s/ Fred A. Middleton - ----------------------------------- Fred A. Middleton General Partner 21278100 -----END PRIVACY-ENHANCED MESSAGE-----